Pharmalot… Pharmalittle… G’Night, All
2 CommentsBy Ed Silverman // October 2nd, 2007 // 8:58 pm
A slow end to a busy day, but that was only due to a slight under-the-weather feeling. Perhaps, a prescription medicine is in order. Meanwhile, a good book and a night of rest are beckoning. We wish you the same…
Using both meds and therapy helps depressed teenagers get better faster than a drug or therapy alone, according to a government-funded study in the Archives of General Psychiatry (subscription may be required). The approach also yielded fewer incidents of the suicidal thoughts or behavior linked to antidepressants.
Biogen Idec stock fell the most in more than seven months after analysts said the biotech’s forecast for the Tysabri multiple sclerosis med may be way too optimistic, Bloomberg News reports. Until now, speculation persisted about a takeover, given the recent stake purchased by Carl Icahn.
And finally, Cipla is now the top drugmaker in India’s domestic market through the first seven months of the year, overtaking Glaxo and Ranbaxy Laboratories, according to The Times of India.
Lisa Van S
Ed,
Is every Reporter suffering from amnesia,or,are they suffering a “Senior Moment”
The TADS study (Prozac In Children) Conducted by Dr. March of Duke Univ., became a hot issue in February and September of 2004 during FDA and Congressional haerings.
Dr March was quoted in the Washington Post saying, “by the technical definition of the FDA, it would require the study be considered negative.”
On Sept 23, 2004 Dr. Mosholder testified,under oath before Congress,and stated that the TADS Study did not meet FDA safety and efficacy standards for approval….
Reporters must dilligent and truthful in their reporting….And stop providing free INFOMERCIALS for the industry.
Lisa Van S
Ed,
It should also be noted that Dr. March was a paid consultant for Solvay Pharmaceutical in Solvay’s defense over the “Infamous Columbine Tragedy.”……..
Someone should ask Dr. March how much Solvay payed him.
He was asked during the FDA hearings,he walked away and declined to answer.